ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/12/21 | 1,980 | 1,987 | 1,961 | 1,970 | +22 | +1.1% | 38,300 |
| 2021/12/20 | 1,980 | 1,985 | 1,947 | 1,948 | -44 | -2.2% | 32,800 |
| 2021/12/17 | 2,004 | 2,008 | 1,972 | 1,992 | -9 | -0.4% | 40,700 |
| 2021/12/16 | 1,999 | 2,003 | 1,986 | 2,001 | +27 | +1.4% | 34,700 |
| 2021/12/15 | 1,967 | 1,989 | 1,963 | 1,974 | +7 | +0.4% | 39,000 |
| 2021/12/14 | 1,966 | 1,985 | 1,958 | 1,967 | +4 | +0.2% | 33,800 |
| 2021/12/13 | 2,000 | 2,000 | 1,959 | 1,963 | -12 | -0.6% | 24,300 |
| 2021/12/10 | 1,985 | 1,989 | 1,962 | 1,975 | -7 | -0.4% | 48,300 |
| 2021/12/09 | 1,987 | 1,999 | 1,977 | 1,982 | -7 | -0.4% | 30,000 |
| 2021/12/08 | 1,999 | 2,002 | 1,982 | 1,989 | +4 | +0.2% | 42,500 |
| 2021/12/07 | 1,929 | 1,994 | 1,929 | 1,985 | +58 | +3% | 44,800 |
| 2021/12/06 | 1,931 | 1,945 | 1,923 | 1,927 | -23 | -1.2% | 60,600 |
| 2021/12/03 | 1,951 | 1,956 | 1,939 | 1,950 | +15 | +0.8% | 43,000 |
| 2021/12/02 | 1,899 | 1,951 | 1,899 | 1,935 | +18 | +0.9% | 82,400 |
| 2021/12/01 | 1,906 | 1,940 | 1,905 | 1,917 | -2 | -0.1% | 49,900 |
| 2021/11/30 | 1,935 | 1,967 | 1,917 | 1,919 | -16 | -0.8% | 106,800 |
| 2021/11/29 | 1,951 | 1,957 | 1,931 | 1,935 | -53 | -2.7% | 87,200 |
| 2021/11/26 | 1,999 | 2,003 | 1,970 | 1,988 | -14 | -0.7% | 72,100 |
| 2021/11/25 | 2,010 | 2,010 | 1,992 | 2,002 | -4 | -0.2% | 28,000 |
| 2021/11/24 | 2,008 | 2,042 | 2,006 | 2,006 | ±0 | ±0% | 45,500 |
| 2021/11/22 | 1,996 | 2,011 | 1,995 | 2,006 | -10 | -0.5% | 20,200 |
| 2021/11/19 | 2,003 | 2,016 | 1,996 | 2,016 | +9 | +0.4% | 43,600 |
| 2021/11/18 | 1,994 | 2,017 | 1,986 | 2,007 | +13 | +0.7% | 48,400 |
| 2021/11/17 | 2,030 | 2,048 | 1,994 | 1,994 | -49 | -2.4% | 45,600 |
| 2021/11/16 | 2,028 | 2,064 | 2,028 | 2,043 | -5 | -0.2% | 32,000 |
| 2021/11/15 | 2,095 | 2,095 | 2,040 | 2,048 | -37 | -1.8% | 32,000 |
| 2021/11/12 | 2,055 | 2,097 | 2,055 | 2,085 | +27 | +1.3% | 43,700 |
| 2021/11/11 | 2,027 | 2,059 | 2,024 | 2,058 | +23 | +1.1% | 25,100 |
| 2021/11/10 | 2,050 | 2,053 | 2,025 | 2,035 | -38 | -1.8% | 35,700 |
| 2021/11/09 | 2,047 | 2,083 | 2,047 | 2,073 | -10 | -0.5% | 47,400 |
| 2021/11/08 | 2,131 | 2,149 | 2,075 | 2,083 | -58 | -2.7% | 68,500 |
| 2021/11/05 | 2,151 | 2,185 | 2,102 | 2,141 | +131 | +6.5% | 130,500 |
| 2021/11/04 | 2,100 | 2,108 | 2,010 | 2,010 | -81 | -3.9% | 95,500 |
| 2021/11/02 | 2,100 | 2,126 | 2,085 | 2,091 | -9 | -0.4% | 49,600 |
| 2021/11/01 | 2,060 | 2,105 | 2,050 | 2,100 | +66 | +3.2% | 97,600 |
| 2021/10/29 | 2,003 | 2,034 | 2,003 | 2,034 | +52 | +2.6% | 46,800 |
| 2021/10/28 | 2,011 | 2,028 | 1,982 | 1,982 | -34 | -1.7% | 66,400 |
| 2021/10/27 | 2,035 | 2,035 | 2,014 | 2,016 | -14 | -0.7% | 22,300 |
| 2021/10/26 | 2,022 | 2,034 | 2,016 | 2,030 | +20 | +1% | 16,300 |
| 2021/10/25 | 2,019 | 2,038 | 2,000 | 2,010 | -24 | -1.2% | 28,300 |
| 2021/10/22 | 2,000 | 2,049 | 1,999 | 2,034 | +14 | +0.7% | 27,900 |
| 2021/10/21 | 2,019 | 2,029 | 2,010 | 2,020 | -7 | -0.3% | 20,700 |
| 2021/10/20 | 2,034 | 2,041 | 2,016 | 2,027 | +2 | +0.1% | 29,100 |
| 2021/10/19 | 2,037 | 2,047 | 2,022 | 2,025 | -15 | -0.7% | 23,200 |
| 2021/10/18 | 2,050 | 2,056 | 2,020 | 2,040 | -5 | -0.2% | 29,400 |
| 2021/10/15 | 2,025 | 2,050 | 2,010 | 2,045 | +36 | +1.8% | 46,800 |
| 2021/10/14 | 2,010 | 2,010 | 1,994 | 2,009 | -7 | -0.3% | 29,000 |
| 2021/10/13 | 2,030 | 2,030 | 2,016 | 2,016 | -12 | -0.6% | 34,400 |
| 2021/10/12 | 2,026 | 2,032 | 2,010 | 2,028 | -10 | -0.5% | 32,700 |
| 2021/10/11 | 2,022 | 2,038 | 2,006 | 2,038 | +23 | +1.1% | 24,600 |
901～
950
件表示中 / 3770件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 204,700円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 265,700円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 311,500円 | +5.1% | -7.0% | 2.57% | 20.45倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 241,900円 | +4.1% | -3.1% | 2.40% | 21.01倍 | 1.83倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 152,500円 | -2.4% | -52.3% | 3.74% | 18.25倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
